PUBLISHER: TechNavio | PRODUCT CODE: 1584023
PUBLISHER: TechNavio | PRODUCT CODE: 1584023
The digital therapeutics market is forecasted to grow by USD 19174.9 mn during 2023-2028, accelerating at a CAGR of 32.59% during the forecast period. The report on the digital therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, advancements in technology in digital therapeutics, and growing adoption of smartphones and connected devices.
Technavio's digital therapeutics market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 25.92% |
CAGR | 32.59% |
Incremental Value | $19174.9 mn |
By Product
By End-user
By Geographical Landscape
This study identifies the rising adoption of personalized and adaptive interventions as one of the prime reasons driving the digital therapeutics market growth during the next few years. Also, integration of artificial intelligence and machine learning in digital therapeutics and partnerships and collaborations between pharmaceutical and technology companies will lead to sizable demand in the market.
The report on the digital therapeutics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading digital therapeutics market vendors that include 2Morrow Inc., Akili Inc., Alphabet Inc., Better Therapeutics Inc., BigHealth , Brain+ ApS, Canary Health, Click Therapeutics Inc, DarioHealth Corp., Digital Therapeutics Alliance Inc. , GAIA AG, Jogo Health Inc., Limbix Health Inc., Medtronic PLC, Noom Inc., Omada Health Inc., Pear Therapeutics Inc., ResMed Inc., Teladoc Health Inc., and WellDoc Inc.. Also, the digital therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: